Yes, this past Spring, two new drugs have been approved by the FDA and made available to individuals with Hepatitis C. The success rate has been as high as 80%.
" The newly approved HCV protease inhibitors boceprevir and telaprevir promise to revolutionize HCV treatment.
Hepatitis C virus (HCV) treatment will change dramatically with the FDA's recent approval of two new oral HCV protease inhibitors, boceprevir and telaprevir. When used in combination with current standard therapy (peginterferon and ribavirin [PR]), these new drugs substantially improve cure rates and often reduce the overall duration of therapy".
Untreated Hepatitis C leads to cirrhosis and liver cancer.
Hope this answers your questions.